Nalaganje...
Chronic lymphocytic leukemia treatment algorithm 2018
The treatment landscape for patients with chronic lymphocytic leukemia (CLL) has changed considerably with the introduction of very effective oral targeted therapies (such as ibrutinib, idelalisib, and venetoclax), and next-generation anti-CD20 monoclonal antibodies (such as obinutuzumab). These age...
Shranjeno v:
| izdano v: | Blood Cancer J |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6170426/ https://ncbi.nlm.nih.gov/pubmed/30283014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0131-2 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|